EyePoint Pharmaceuticals
EYPT
EYPT
60 hedge funds and large institutions have $184M invested in EyePoint Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
8% less capital invested
Capital invested by funds: $200M → $184M (-$15.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
60
Holding in Top 10
1
Calls
$3.38M
Puts
$752K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$2.04M | |
| 3 | +$1.94M | |
| 4 |
Millennium Management
New York
|
+$1.89M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.77M |
Top Sellers
| 1 | -$7.11M | |
| 2 | -$2.36M | |
| 3 | -$2.06M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$2.03M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$823K |